Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
certified, inflow, Medable, outflow, round
Removed:
bid, dollar, experienced, remotely
Financial report summary
?Risks
- Uncertainties associated with the transaction with Thermo Fisher Scientific Inc. could adversely affect our business, results of operations and/or financial condition.
- Failure to complete the Merger could adversely affect our business and the market price of our shares of common stock.
- The Merger Agreement contains provisions that limit our ability to pursue alternatives to the Merger.
- Potential litigation instituted against us and our directors challenging the proposed Merger may prevent the Merger from becoming effective within the expected timeframe or at all.
Management Discussion
- The decrease in operating cash flows of $181.6 million was due to a $378.8 million decrease in cash from the changes in operating assets and liabilities, partially offset by a $197.2 million increase in net income and non-cash reconciling items. The change in operating assets and liabilities was primarily due to period over period fluctuations in the timing of collections and payments, with the use of cash from (i) net accounts receivable (defined as the sum of period-end balances of accounts receivable and unbilled services net of unearned revenue), (ii) income taxes, (iii) other assets and (iv) operating lease liabilities being unfavorable and the source of cash for (i) prepaid expenses and other current assets and (ii) accounts payable, accrued expenses and other liabilities being favorable.